Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Express Scripts
Colorcon
Federal Trade Commission
QuintilesIMS
Boehringer Ingelheim

Generated: June 24, 2019

DrugPatentWatch Database Preview

Litigation Details for Simonian v. Allergan, Inc. (N.D. Ill. )

Try a free trialSee Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Simonian v. Allergan, Inc.
The small molecule drug covered by the patents cited in this case is ➤ Try a Free Trial .

Details for Simonian v. Allergan, Inc. (N.D. Ill. )

Date Filed Document No. Description Snippet Link To Document
2010-11-30 45 products with two expired patents, namely U.S. Patent Numbers 4,839,342 (“the ‘342 patent”) and 4,649,047 (“…expired ‘342 and ‘047 patents, the product was also marked with a separate patent that is both valid and… is marked with unexpired U.S. Patent No. 5,474,979 (“the ‘979 patent”), Defendant submits that the Court…with an expired patent regardless of whether the article is also marked by valid patents, the Court denies…litigation of patent infringement cases and which regularly prosecutes or oversees patent prosecution. External link to document
2011-04-28 70 products with two expired patents, namely U.S. Patent Numbers 4,839,342 (“the ‘342 patent”) and 4,649,047 (“…litigation of patent infringement cases and which regularly prosecutes or oversees patent prosecution.…article with an expired patent, even if it also marked that article with valid patents. (Id.) On… of the U.S. Patent and Trademark Office (“PTO”) after the filing of any type of patent action, is generic…(“the ‘047 patent”). (R. 1.) On March 4, 2011, Allergan filed a motion for judgment on the pleadings, External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Healthtrust
Julphar
Boehringer Ingelheim
US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.